Dasatinib in children and adolescents with relapsed of refractory leukemia: results of the CA 180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium

C.M. Zwaan, C Rizzari, F Mechinaud, DL Lancaster, T Lehrnbecher, Vincent van der Velden, BB Beverloo, Monique den Boer, Rob Pieters, D Reinhardt, M Dworzak, J Rosenberg, G Manos, S Agrawal, L Strauss, A Baruchel, PR Kearns

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2460-2468
Number of pages9
JournalJournal of Clinical Oncology
Issue number19
Publication statusPublished - 2013

Cite this